Amgen and Xencor enter cancer immunotherapy and inflammation collaboration 17 September 2015 | By Victoria White The research collaboration brings together Amgen's capabilities in target discovery and protein therapeutics with Xencor's XmAb bispecific technology platform...
Piramal encourages pharma to embrace green chemistry 17 September 2015 | By Victoria White Piramal has launched a series of green chemistry initiatives and is asking all its partners to evaluate the greenness of the chemical pathways they are using...
CEVEC and Généthon to develop lentivirus packaging cell lines 17 September 2015 | By Victoria White CEVEC is to grant Généthon a license for the development of lentivirus packaging cell lines based on CEVEC’s CAP GT technology...
Dementia Consortium funds project focusing on ALS and FTLD 16 September 2015 | By Victoria White A team at the International Centre for Genetic Engineering and Biotechnology (ICGEB) will join forces with MRC Technology to take on the project...
USP19 inhibition protects against muscle wasting 15 September 2015 | By Victoria White Researchers have discovered a new gene, USP19, involved in the muscle wasting syndrome cachexia that could be a good target for drug development...
Chimerix gets contract extension for smallpox treatment 15 September 2015 | By Victoria White Chimerix has extended its contract with BARDA for the development of brincidofovir as a medical countermeasure to treat smallpox...
Auspherix and Domainex expand antibiotics partnership 15 September 2015 | By Since initiating the project in 2014, significant progress has been made towards the invention of new compounds with activity against both gram-positive and gram-negative bacteria...
Desktop Genetics raises £1.37M to accelerate development of DESKGEN 15 September 2015 | By Victoria White DESKGEN allows researchers to expertly design and perform CRISPR-based genome editing experiments in virtually any cell line or species...
Transatlantic partnership to develop treatments for pancreatic cancer 14 September 2015 | By Victoria White The five-year programme will focus on the development of ‘nanomedicine’ in the treatment of pancreatic cancer, for which current treatment options are limited...
Cancer Research UK and MedImmune launch biotherapeutics research centre 14 September 2015 | By Victoria White The new laboratory, opened in Cambridge, will focus on the discovery and development of novel biologic cancer treatments and diagnostics...
Researchers discover new group of antibiotics 14 September 2015 | By Victoria White The potential new antibiotics are unlike contemporary antibiotics because they contain iridium, a silvery-white transition metal...
Takeda joins malaria and TB drug discovery consortium, WIPO Re:Search 14 September 2015 | By Victoria White WIPO Re:Search provides access to the intellectual property of certain pharmaceutical compounds, technologies, know-how and data for R&D activities around TB and malaria...
Researchers develop a new computational method to study cancer drug effects 11 September 2015 | By Victoria White Researchers have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry experiments...
New technique improves the selectivity of kinase inhibitors 11 September 2015 | By Victoria White The new technique could cut the potential for side effects and help usher kinase inhibitors past strict regulatory hurdles...
Scientists discover why levodopa can lead to dyskinesia 11 September 2015 | By Victoria White Researchers have discovered why long-term use of levodopa, a treatment for Parkinson's disease, commonly leads to a movement problem called dyskinesia...
